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PATENTS AT ISSUE: THE DATA BEHIND THE
PATENT TROLL DEBATE
JonathanH. Ashtor, Michael J. Mazzeo, and Samantha Zyontz*

INTRODUCTION

The debate over "patent trolls"' is raging at full tilt and its fury is
stoked by fundamental questions about patent assertion. Both sides are
struggling to understand which patent assertion practices are consistent with
the purpose of patent rights and which are abusive and result in net social
costs. This Article addresses patent assertion concretely through empirical
analysis of actual infringement awards. In particular, this Article studies all
* Jonathan H. Ashtor is an associate at Skadden, Arps, Slate, Meagher & Flom LLP. Michael J.
Mazzeo is an associate professor of management and strategy at the Kellogg School of Management,
Northwestern University, and a faculty associate at the Institute for Policy Research, Northwestern
University. Samantha Zyontz is a graduate student in technological innovation, entrepreneurship, and
strategic management at MIT-Sloan School of Management. The Authors are grateful to Larry Ranallo,
Christopher Barry, and Ronan Arad, and to PricewaterhouseCoopers LLP for licensing to us the proprietary database on which these studies are built. We also thank the Center for the Protection of Intellectual
Property at George Mason University School of Law and the organizers of their recent conference, "The
Commercial Function of Patents in Today's Innovation Economy," held on September 12-13, 2013, at
which these studies were presented. The Authors are also grateful for the comments and contributions
received on previous versions of these studies, including from F. Scott Kieff and Geoffrey J. Lysaught
on previous outlines, Mark Schankerman on our work regarding the predictability of U.S. patent infringement awards, and many others at various conferences (including Josh Wright, David Schwartz,
Max Schanzenbach, and Henry Butler, to name a few). Elise Nelson and Matthew Sibery must also be
thanked for their tireless research assistance on previous versions. The views expressed are solely those
of the Authors and do not reflect the views of others, including PricewaterhouseCoopers LLP; Northwestern University; the Massachusetts Institute of Technology; Skadden, Arps, Slate, Meagher & Flom
LLP (or its attorneys or clients); or any of their affiliates.
1 This Article uses the term "patent trolls" in order to speak directly to participants in the debate
who label various patent assertion entities "trolls" without qualification. The Authors, however, have
reservations about the pejorative nature of this term and retain the quotation marks to preserve a degree
of impartiality. As discussed in Part II, there is no clear definition of "patent troll," and many academics
and policymakers use the term loosely to describe any patent holder thought to be abusing his or her
patent rights. This subjective approach suggests potential bias in empirical analysis and policy discussion. In particular, given that this study attempts to understand precisely what patent assertion practices
result in net social costs and can be said to abuse the rights intended to be afforded by patents, it cannot
start with the tautology of labeling the abuse before it is found. And as stressed throughout this Article,
patent assertion and patent value are intrinsically related, and there is too great a risk of inadvertently
undermining socially beneficial patent value through uninformed reform efforts. Particularly when new
patent value may be derived from novel patent assertion and monetization techniques and fundamental
evolution of the patent marketplace, it is best to be careful to not forestall patent innovation in the name
of technological progress.
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awards granted for findings of patent infringement in U.S. district courts
between 1995 and 2011, and, with targeted analyses, focuses on cases involving patent assertion entities ("PAEs"). This Article specifically investigates certain principal assumptions about patent assertion which have been
raised in the debate and further tests some of the leading policy proposals
that are currently being considered. In so doing, this Article seeks to inform
the "patent troll" debate and helps answer some of the key questions driving
it.
Part I below discusses the background for this study, addressing the
current "patent troll" debate and some of the leading reform proposals that
have been advanced. Part H describes the dataset used. Part III explains the
empirical methodology used and highlights principal findings from previous work analyzing PAE and other nonpracticing entity ("NPE") litigations.
Part IV investigates PAE assertion practices directly and analyzes key questions that have been raised in the "patent troll" debate. Part V provides a
summary of results and concluding remarks.
The principal findings are as follows:
A. PAE Patent Quality: This Article analyzes PAE success rates and
quality-related characteristics of the patents asserted to investigate fears that
PAEs typically assert low-quality patents and bring frivolous cases.
1. PAE Success Rates: Approximately equal success rates exist
for PAEs as for other patent claimants in the cases studied. Specifically,
PAEs won 28 percent (45 out of 160) of the cases they brought, and all other plaintiffs won 32 percent (509 out of 1,591) of their cases. The 4 percent
difference is not statistically significant here.
2. Characteristicsof PAE Patents: This Article studies certain
intrinsic characteristics that have widely been associated with patent quality
in cases where the PAE or non-PAE claimant, respectively, was granted an
award for infringement.
i. Number of Claims: PAE patents had a higher number of
claims than patents asserted by other patent holders in the cases studied. On
average, PAE patents had 33.39 claims and non-PAE patents had 21.24
claims.
ii. Number of ForwardCitations: PAE patents had a higher number of forward citations than patents asserted by other patent holders
in the cases studied. Specifically, PAEs asserted patents with 22.35 forward
citations on average, and non-PAEs asserted patents with 19.27 forward
citations on average.
iii. Number of Patents: PAEs asserted a higher number of
patents per case on average than other patent holders in the cases studied.
PAEs assert 3.85 patents per case on average, while non-PAE plaintiffs
assert 2.22 patents per case.
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B. PAE Litigation Strategy: This Article studies PAE litigation strategy along the following parameters: (1) PAE decision rates, which provide
information relevant to settlement rates; (2) venue of PAE cases; and (3)
length of PAE litigations relative to non-PAE litigations in cases finding
infringement.
1. PAE Decision Rates: PAE cases account for only 9 percent
of all cases studied in which there was a final decision on the merits. This
low proportion is despite the fact that PAEs are reportedly initiating more
infringement lawsuits than non-PAEs. Taken together, these findings could
indicate that PAEs are more likely to settle their cases than other patent
plaintiffs.
2. PAE Venue: Approximately 50 percent of PAE cases are
concentrated in five U.S. district courts: the Eastern District of Texas, the
Northern District of Illinois, the District of Delaware, the Northern District
of California, and the Central District of California. The Eastern District of
Texas also provided PAEs the highest win rate of any other district court
that decided at least five PAE cases. These results were not driven by one
PAE litigating many times in a single venue.
3. Length of PAE Litigations: There is no statistically significant difference between the length of fully litigated cases brought by PAEs
relative to other patent holders. In all cases where the patent holder was
successful from 1995 to 2011, PAE cases lasted 1,014 days (2.78 years) and
non-PAE cases lasted 1,040 days (2.85 years) on average. This difference is
not statistically significant.
C. PAE Patent Acquisitions and Opponents: Finally, this Article
delves deeper into the patents asserted and types of defendants sued by
PAEs, looking for differences in: (1) the age and assignment history of PAE
patents versus non-PAE patents, which speak to concerns that PAEs principally extract after-market value from patents they have acquired from inventors or technology companies; and (2) the entity size of defendants sued
by PAEs and non-PAEs in cases finding infringement.
1. Age and Assignment History of PAE Patents:
i. Patent Age: There is no statistically significant difference in patent age at the time of trial between PAE and non-PAE plaintiffs
who were awarded damages in the cases studied. The average patent age at
trial is 2,149 days (5.89 years) for PAEs and 2,318 days (6.35 years) for
non-PAEs in these cases.
ii. Number of Assignments: PAE patents had a slightly
higher number of assignments prior to trial than patents asserted by other
claimants. PAE patents had 1.481 assignees on average while non-PAE
patents had 1.317 assignees in the cases studied, and this difference is significant at the 5 percent level.
2. Size of Defendants: PAEs tend to litigate against large companies more often than non-PAEs, although the difference is not significant.
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PAEs sued Fortune 500 defendants in 22 percent of cases and non-PAEs
sued Fortune 500 defendants in 13 percent of cases, based on data of infringement awards in cases decided between 1995 and 2008.
I.

BACKGROUND

The core questions in the "patent troll" debate include issues of whether and to what extent patent assertion practices take a toll on innovation,
whether PAEs are asserting low-quality patents and seeking quick settlement payoffs,3 whether start-ups suffer more harm through patent assertions
than the benefits they gain from patent market liquidity,4 and whether high
litigation costs are shifting the economics of patent assertion to favor
PAEs. s These questions implicate the underlying tension between "patent
monetization" and "patent assertion." Which types of patent monetization
practices are legitimate and which types exceed the intended scope of the
patent grant? Does "after-market" patent value extracted by PAEs deserve
the same status as the patent value derived by practicing entities? More
generally, should PAEs be entitled to property rule protection for their patent rights-i.e., should they have the right to exclude infringers--or should
liability rules apply? This Article seeks to inform the policy debate about
''patent trolls" and modem patent assertion practices by studying some of
the key questions concretely, through empirical analysis of patent infringement award data.
These questions are of central importance and urgency, as public attention has been captivated by the "patent troll" debate and calls for reform
measures are rapidly rising. The White House recently issued a report condemning "patent trolls" and calling for investigation and remediation of

2 See, e.g., Richard Finger, Voicing Both Sides of the Patent Troll Debate, FORBES (Sept. 10,
2013, 5:25 PM), http://www.forbes.com/sites/richardfinger/203/09/I0/voicing-both-sides-of-the-patent
-troll-debate/ (discussing costs and benefits of PAE practices).
3

See

U.S.

GOV'T

ACCOUNTABILITY OFFICE, GAO-13-465, INTELLECTUAL PROPERTY:
ASSESSING FACTORS THAT AFFECT PATENT INFRINGEMENT LITIGATION COULD HELP IMPROVE PATENT

QUALITY 28 (2013) [hereinafter GAO PATENT ASSERTION STUDY], available at http://www.gao.gov/
assets/660/657103.pdf ("Several of the stakeholders we spoke with, including representatives from
PMEs, operating companies, and legal commentators, said that many recent patent infringement lawsuits are related to the prevalence of low-quality patents; that is, patents with unclear property rights,
overly broad claims, or both.").
4 See, e.g., Colleen V. Chien, Patent Assertion and Startup Innovation, NEW AM. FOUND. OPEN
TECH. INST., 18-22 (Sept. 2013), http://newamerica.net/sites/newamerica.net/files/policydocs/Patent%20
Assertion%20and%20Startup%201nnovation.pdf.
5

See, e.g., EXEC. OFFICE OF THE PRESIDENT, PATENT ASSERTION AND U.S. INNOVATION 9

(2013) [hereinafter WHITE HOUSE REPORT], available at http://www.whitehouse.gov/sites/default/
files/docs/patent report.pdf ("[Tihe harassing litigation tactics of some PAEs, combined with substantial
litigation costs... have added significant costs to the innovation ecosystem .... ").
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many of their assertion practices.6 However, this report refers to PAEs and
"patent trolls" interchangeably,7 and it gives little guidance as to which
practices are harmful on balance or what remedial measures are likely to be
effective. Similarly, President Barack Obama expressly supports legislative
measures against certain patent assertion practices, stating that "our efforts
at patent reform only went about halfway to where we need to go ... [toward] smarter patent laws."8 However, the executive branch offers no road
map for identifying true threats and remediating them.
Academic scholarship and policy papers are further engaging in the
"patent troll" debate from a variety of angles. A recent study by Professors
James Bessen and Michael Meurer seeks to measure the costs of NPEs on
practicing firms, estimating $29 billion of direct costs in 2011.9 Professor
Colleen V. Chien studies the costs and benefits of patent assertion on technology start-ups, based on surveys of venture capitalists and technology
firms.'" This study concludes that the costs to small firms exceed the benefits of increased liquidity in patent markets. Among the reform proposals,
Professor Chien recommends specific legislative measures including: (1)
requiring patent plaintiffs to identify in their initial demand letters the specific basis for infringement claims and disclose licenses they have previously granted under the asserted patents;" and (2) imposing statutory limits on
the liability of start-ups and their customers for patent infringement. 2
Additionally, the Government Accountability Office ("GAO") recently
issued a study of PAE activity, based on interviews of 44 stakeholders
knowledgeable about patent assertion and analysis of a random sample of
500 lawsuits from 2007 to 2011 reported in Lex Machina, RPX, and other
sources.' 3 The GAO sought to study four objectives, namely:
(1) what is known about the volume and characteristics of recent patent litigation activity; (2)
the views of stakeholders knowledgeable in patent litigation on what is known about the key
6 Id. at 12-13.
7 Id. at 2 ("This report looks particularly at firms who do not practice the patents they own and
instead engage in aggressive litigation to collect license and other fees from alleged infringers. A review
of the evidence suggests that on balance, such patent assertion entities (PAEs) (also known as "patent

trolls") have had a negative impact on innovation and economic growth." (emphasis added)).
8 The White House, President Obama on Patents in a Google+ Hangout, YOUTUBE (Feb. 21,
2013), http://www.youtube.com/watch?v=VQ4ZoOXyNsw#t= 1m20s.
9 James Bessen & Michael J. Meurer, The Direct Costsfrom NPE Disputes 3 (Boston Univ. Sch.
of Law, Working Paper No. 12-34, 2012), available at http://www.bu.edulaw/faculty/scholarship/
workingpapers/documents/BessenJ-MeurerM062512revised7-2013.pdf.
10 Chien, supra note 4.
11 Id.at 5 ("Make patent risks more manageable for startups by requiring demand letters and
complaints to disclose the real-party in interest, claim charts, related litigations and reviews, and licenses that could cover the target.").
12 Id. ("Make startups less attractive targets by limiting the liability of downstream users and the
precedential value of the settlements signed by small companies.").
13 GAO PATENT ASSERTION STUDY, supra note 3, at 4-7 (describing data and methodology).
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factors that have contributed to recent patent litigation; (3) what developments in the judicial
system may affect patent litigation; and (4) what actions, if any, has [the U.S.
4 Patent and
Trademark Office] recently taken that may affect patent litigation in the future.'

Among their findings, the GAO reported that the number of infringement
suits increased significantly in 2011,"5 and PAEs (termed "Patent Monetization Entities" or "PMEs" in the report) brought approximately 19 percent of
all suits in the four years studied.' 6 The GAO study also reported evidence
of practicing entities partnering with PAEs in order to enforce their patents,
such as by suing their competitors while avoiding the risk of countersuit. 7
The GAO also found a high incidence of software patents being asserted,
with approximately 46 percent of all suits and 84 percent of PAE suits during this time period involving software patents. 8 The GAO also reported
data on venue and outcomes of recent PAE lawsuits,' 9 among other characteristics.
Most recently, the Federal Trade Commission ("FTC") has launched
an investigation of PAEs, their patent holdings, and the assertion and licensing practices they conduct. On September 27, 2013, the FTC commenced the public comment period for a "proposal to gather information
from approximately 25 companies that are in the business of buying and
asserting patents, known as [PAEs]. ''2' The FTC proposed a formal Section
6(b) study intended to "provide a better understanding of PAE activity and
its costs and benefits." '2' The proposed information requests seek extensive
information regarding each PAE's corporate structure, patent holdings, patent portfolio valuation and organization (i.e., the PAE's rationale for organizing its patent assets into specific portfolios and methods for valuing
these portfolios), details of all patent acquisitions, transfers and licenses
in/out, details of all patent assertion activity (including demands as well as
formal litigation), and financial information regarding costs and revenues
associated with their patent holdings.2 Information requests will also be
sent to fifteen other entities that assert patents in the wireless communications field. 3

14
15
16
17
18

Id. at4.
Id. at 14.
Id. at 17.
Id. at 19.

19

GAO PATENT ASSERTION STUDY, supra note 3, at 23-26.

20

Press Release, Fed. Trade Comm'n, FTC Seeks to Examine Patent Assertion Entities and Their

Id. at 21-22.

Impact on Innovation, Competition (Sept. 27, 2013), available at http://www.ftc.gov/news-events/pressreleases/2013/09/ftc-seeks-examine-patent-assertion-entities-their-impact.
21 Id.
22

id.

23

Id.
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It is important to note that the FTC investigation was motivated by an
earlier FTC finding that there is "a lack of empirical data" regarding PAE
practices and their effects.24 This is somewhat at odds with the rising calls
for substantive legislative reforms being voiced by academics and policymakers. Particularly given the symbiotic relationship of patent assertion and
patent value, the stakes are high to ensure that efforts intended to prevent
abusive practices do not accidentally also undermine patent value. To walk
this tightrope, it is crucial to develop an empirical understanding of patent
assertion practices and their true costs and benefits.
This delicate balance is reminiscent of the patent reform debates leading up to passage of the America Invents Act ("AIA"). At the time, many
were concerned that patent infringement awards were "excessive" and "unpredictable," and legislative measures were proposed to increase the burdens of proof on patent holders and substantively limit their remedies." The
potential side effects of these prescriptions were unknown, but support for
them continued to grow among academics and policymakers alike. Against
this backdrop, an empirical study called into serious question whether damage awards were indeed "excessive. "26 That study found that the awards
distribution of decided cases is highly skewed by a very small number of
very large and noticeable "blockbuster" verdicts. Furthermore, award value
is highly deterministic and predictable from observed factors.27 This analysis strongly suggested that the risk of devaluing U.S. patent assets by curtailing infringement remedies significantly outweighed any specific idiosyncratic issues affecting award value. In the end, the AIA did not enact
changes to the law of infringement remedies, and the reforms that had been
proposed to Section 284 on damages were left on the Senate floor.
Today, there exists a similar set of questions, and a similar lack of data
analysis, about the empirical costs and benefits of patent assertion practices.
It is crucial to determine which patent assertion practices are harmful and
which are legitimate-that is, which patent plaintiffs are "trolls" and which
are properly enforcing their rights. In the Parts that follow, this Article aims
to inform the debate with direct analysis of PAE practices based on litigated
infringement cases.

24
25

Id.
See, e.g., S.REP. NO. I11-18, at 8 (2009) ("[Dlamage awards.., are too often excessive and

untethered from the harm that compensatory damages are intended to measure.").
26 Michael J. Mazzeo, Jonathan Hillel & Samantha Zyontz, Explaining the "Unpredictable":An
Empirical Analysis of U.S. Patent Infringement Awards, 35 INT'L REV. L. & EcON. 58, 58-60 (2013).
27 Id. at 66.
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DATASET

This analysis of PAEs and their assertion practices focuses on cases
litigated in U.S. district courts which have resulted in a final decision on
validity, infringement, and liability. As such, this Article offers a specific
perspective of patent assertion by PAEs-it is not dealing with demand
letters or filed complaints, but instead focuses on cases that have reached a
final decision on infringement liability.
One might question this approach, particularly given that many of the
concerns regarding PAE practices relate to the costs and other potential
harms of pending and threatened litigation, and not simply the final liability
of an infringement award. In fact, the information available from decided
cases offers important insight into assertion practices and also provides a
road map for further areas of inquiry. For example:
1. Decided cases are the end result of patent assertions. There is no
way to assess the risk and magnitude of infringement liability ex ante without knowing the data on awards and patent-holder success rates. And, although the vast majority of patent cases settle, settlements are negotiated in
the shadow of litigation. Both parties must evaluate litigation expectations
in order to determine their settlement strategy.
2. Decided PAE cases also provide some insight into PAE litigation
practices. Decided cases offer detailed data for a number of important assertion parameters, such as: (i) where PAEs file their cases; (ii) the types of
defendants they sue; (iii) the industries in which they operate; and (iv) the
characteristics of the patents they assert. Understanding the "who," "what,"
and "where" of PAE assertions is critical to assessing the actual costs and
comparative benefits of these practices.
3. Decided cases provide a unique perspective on PAE litigation
strategy and success rates, insights that cannot be gleaned from case filings
or survey data alone. Examining decided cases allows for an evaluation of
PAE success rates in court (which informs ex ante risk assessment), a
measurement of how long PAE proceedings last relative to other patent
cases (which relates to litigation expenses), and inferences about the settlement rates of PAEs relative to other types of patent-holder plaintiffs (which
provides evidence of PAE incentives).
4. Perhaps most relevant to the central question raised in the "patent
troll" debate, analysis of PAE decided cases relative to non-PAE decided
cases provides a means to assess whether PAEs on average are "abusing"
their patent fights, and whether proposed reforms can effectively prevent
such abuse. If there are significant differences between PAE decided cases
and non-PAE decided cases, these variations could reflect abusive practices
and give clues as to how to prevent them. Conversely, if PAE cases are
indistinguishable from similar non-PAE cases, this undermines arguments
of PAE "abuse" and moreover raises the specter that efforts to curtail PAE
assertions might also undermine the rights of practicing entities, their abil-
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ity to enforce these rights, and the overall value they can realize from their
patent holdings.
5.
Yet, there are important limitations to data on decided cases
which must be kept in mind when interpreting these results. Particularly
when examining litigation practices of PAEs-such as the types of entities
they sue, the venues they select, the full extent of litigation costs attributable to their assertions, and their settlement behavior--decided cases are
only one piece of the puzzle. Cases filed that do not result in a final decision, and assertions that do not even involve a filed case, may be different
than decided cases. Similarly, if patent-holder wins and losses are significantly different, results drawn from cases awarding damages for infringement may be limited. As mentioned above, data on decided cases can be
invaluable to several lines of inquiry, and as with all data they must be
properly interpreted so that accurate conclusions can be drawn.
This dataset of decided patent cases and damage awards is based upon
a database licensed to us by PricewaterhouseCoopers ("PwC"), which regularly publishes annual and periodically updated Patent Litigation Studies
analyzing its data (the "PwC Studies")." The PwC Studies are regularly
cited by policymakers (including the FTFC in its reports) and academics. The
version of the PwC database used here contains all decided patent cases
reported in Westlaw from 1995 through 2011. This Article supplements the
PwC data with several additional variables regarding the cases, parties, and
patents at issue, and performs various statistical analyses to reach the conclusions reported herein (see Part III below for a discussion of methodology).
The PwC dataset contains 1,751 patent cases reported in Westlaw
which were decided between 1995 and 2011 and reached a decision on patent validity and infringement at summary judgment or trial. Five hundred
and fifty-four of such cases included a finding of validity and infringement
for at least one of the patents asserted, and of those cases 421 had publicly
reported award amounts or were cases related to abbreviated new drug application ("ANDA") litigation-of these, forty-five were ANDA cases with
$0 awards (since damages are not available in ANDA cases). In total, 376
cases resulted in awards greater than $0.
PwC also tracks whether the patent holder in each case is an NPE or a
practicing entity, and the PwC database further codes three subtypes of
NPE: NPE-university, NPE-individual, and NPE-company. PAEs fall into
the third category, and accordingly the analysis is concentrated here. PwC
defines an NPE as "an entity that does not have the capability to design,

28

See, e.g., PRICEWATERHOUSECOOPERS

LLP, 2013 PATENT LITIGATION STUDY [hereinafter

2013 PWC STUDY], available at http://www.pwc.com/enUS/us/forensic-services/publications/assets/
2013-patent-litigation-study.pdf.
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manufacture, or distribute products with features protected by the patent," 29
and this definition is employed here.
The definition of "PAE" varies widely across empirical studies, other
scholarship, and policy papers. As one notable example, the White House
report considers all PAEs to be "patent trolls" and vice versa, and by implication (but without an identifiable distinction) excludes from this definition
any NPEs that "play an important role in U.S. innovation ecosystem, for
example by connecting manufacturers with inventors."3 By contrast, the
FTC in its recent proposed inquiry defines PAEs as "firms with a business
model based primarily on purchasing patents and then attempting to generate revenue by asserting the intellectual property against persons who are
already practicing the patented technologies."'" Also, Professor Chien defines an NPE as "an entity that asserts patents as a business, not including
universities or startups," and uses the terms PAE and NPE interchangeably.32 This variety of definitions causes confusion and complicates the task
of identifying the specific assertion practices associated with PAEs and
studying their likely effects. The PwC definition, which is rooted in objective characteristics of the patent holder, provides a more objective basis for
initial study. An important task for future research would be to determine a
common set of definitions that the field could agree upon and work from.
HI.

METHODOLOGY AND RELEVANT PRIOR RESULTS

The empirical methodology utilized in this Article is summarized as
follows. The PwC dataset is supplemented by coding additional variables
relating to the parties, cases, and patents at issue, generating a comprehensive dataset comprising more than 120 variables for each case record. There
are several unique features of the dataset relevant to the present study. In
particular, the variables include the size of the defendant (measured in
terms of Fortune ranking), the time to trial (measured in days between the
initial case filing and actual trial), and characteristics of the asserted patents, such as number of claims, forward citations, and patent age, which
respectively speak to the breadth of the patent right, prominence relative to
the prior art, and currency in technology markets at the time asserted.
Using this dataset, this Article first conducts a series of distributional
analyses to measure statistics relating to case rates, patent-holder successes,
imbalance in award amounts, and related time trends. Next, this Article
conducts large-scale regression analyses to determine overall predictability
of award value based on observed variables, and further to identify the key
34.

29

Id. at

30

WHITE HOUSE REPORT, supra note 5, at 1.

31 Press Release, Fed. Trade Comm'n, supra note 20.
32 Chien, supra note 4, at 35 nn.2 & 5 (internal quotation marks omitted).
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determinants of award value. Then, this Article focuses on a small number
of specific variables to analyze their particular effects on award size. Drawing from academic literature and the policy debates, this Article targets factors that have been the basis of concern, such as whether the patent holder
is an NPE and whether the underlying "economic value" of the asserted
patents correlates with the final award amount.33 Finally, this Article addresses key points of the policy debates directly, conducting specialized
analyses to investigate the assumptions made and main issues raised.34
Two previous studies using this dataset have been published in peerreviewed law and economics journals. The first, Explaining the Unpredictable, analyzes whether patent infringement awards are "excessive" or "unpredictable," questions that were central to the patent reform debates preceding passage of the AIA. This study conducted large-scale distribution
and regression analyses and found infringement awards to be highly
skewed, with the top eight awards accounting for nearly 50 percent of the
cumulative award amount for the 306 cases through 2008. Awards were
also found to be highly predictable, with identified factors explaining over
75 percent of the variation in award value.36
The second study, Do NPEs Matter?, focused on NPE cases and analyzed whether significant variations could be observed in damages awarded
to NPEs relative to practicing entities (controlling for other case-related
factors). 37 It principally found that there is no statistically significant difference between NPE cases and practicing entity cases in terms of the distribution of award amounts.38 However, it also observed lower win rates39 and
slightly lower award amounts ° for NPEs relative to practicing entities.
33 Several studies have found correlations between these intrinsic patent characteristics and the
likelihood of patents being asserted in litigation. These studies typically use assertion as a proxy for
"patent value." See, e.g., Jean 0. Lanjouw & Mark Schankerman, Characteristicsof Patent Litigation:
A Window on Competition, 32 RAND J. ECON. 129 (2001); Jean 0. Lanjouw & Mark Schankerman,
PatentQuality and Research Productivity:Measuring Innovation with Multiple Indicators, 114 ECON. J.
441 (2004); Jean 0. Lanjouw & Mark Schankerman, Protecting Intellectual PropertyRights: Are Small
Firms Handicapped?, 47 J.L. & ECON. 45 (2004); see also John R. Allison et al., Extreme Value or

Trolls on Top? The Characteristicsof the Most litigatedPatents, 158 U. PA. L. REV. 1 (2009) (studying
litigation rates of patents in specific industries); John R. Allison et al., Valuable Patents, 92 GEO. L.J.
435 (2004); Shawn P. Miller, What's the Connection Between Repeat Litigation and Patent Quality? A

(Partial)Defense of the Most Litigated Patents, 16 STAN. TECH. L. REV. 313 (2013).
34 Where noted, certain of these analyses utilize data on cases decided between 1995 and 2008,
and other analyses address cases decided between 1995 and 2011. The dataset is currently being updated
to include all variables for recent cases.
35 Mazzeo, Hillel & Zyontz, supranote 26.
36

Id. at 63.

37 See generally Michael J. Mazzeo, Jonathan H. Ashtor & Samantha Zyontz, Do NPEs Matter?
Non-PracticingEntities and Patent Litigation Outcomes, 9 J. COMPETITION L. & ECON. 879 (2013).
38 Id. at 903.
39

Id. at 889-90.

40

Id. at 894-96.
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Importantly, this study also found that PAE awards are noticeably different than other NPE awards. Relative to individuals, PAEs have higher
success rates (although universities tend to be more successful than other
NPEs-universities also have higher success rates than the average for all
patent litigants).4' Additionally, PAEs generally are awarded larger amounts
of damages than either individuals or universities in the cases in which they
are successful. Regression analyses also found a positive coefficient for the
PAE variable, indicating that PAEs generally receive equivalent or slightly
higher awards than other types of patent holders.42 The 2013 PwC Study
shows consistent results, finding higher median awards for NPEs relative to
practicing entities.43
The following summarizes the key findings of these previous studies
which are most relevant to the "patent troll" debate addressed herein:'
I. The proportion of decided NPE cases relative to all cases has remained relatively stable over time. Notably, many studies, including the
2013 PwC Study, have observed a significant increase in case filings by
PAEs,45 and coupled with the results of this Article, this could reflect to
some extent a greater willingness of PAEs to settle their claims rather than
litigate to a final decision.46
2. There is a noticeable shift from individuals to PAEs in cases decided in the most recent years studied. Several policy papers and academics
have questioned whether PAEs provide valuable remuneration to inventors
by acquiring or licensing their patents, and the data offer support for such
transfers, showing that patents are now being asserted more frequently by
PAEs than by individuals.
3. PAEs are more successful than individuals in case outcomes,
which is consistent with the hypothesis that they have greater expertise at
determining which patents to assert and at litigating their claims. Coupled
with evidence of upstream patent transfers, this suggests that PAEs may
provide a specialized function in the patent marketplace, efficiently separating technology development from patent enforcement and monetization.
These efficiency gains could flow back to inventors and practicing entities
that license and use patent rights in the form of more accurate market valuations of patent assets and greater liquidity in patent transactions. However,
PAEs may also be commanding high profits from their assertion practices,
41

Id. at 902.

42

Id. at 899-900.

43

2013 PwC STUDY, supra note 28, at 7.
Mazzeo, Ashtor & Zyontz, supra note 37, at 880.
2013 PWC STUDY, supra note 28, at 3.
46 Of course, since settlements are mutual agreements, the defendant's willingness to settle is also
relevant here. Furthermore, since there are other forms of case disposition than only settlements or final
decisions-including dismissal on motion or voluntarily, consolidations, stays, etc.-and since there is a
significant time lag between case filing and final disposition, this study cannot determine the extent to
which the data correspond to actual settlements.
44
45
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which may appropriate some of the efficiency benefits for their private
gain.
4. The distribution of NPE awards is not statistically different from
that of other awards. That is, NPE cases are distributed heavily toward lowvalue cases with only very few high-value outcomes, and the distribution is
indistinguishable from that of practicing entity cases. This suggests that
despite their specialized expertise, NPEs on the whole face similar litigation
risks and factors affecting final award value as do practicing entities.
5. Importantly, NPEs overall are somewhat less successful in the
case outcomes than practicing entities, both in terms of findings of validity
and infringement and in terms of damage award levels in successful cases.
As mentioned, PAEs are more successful than individuals, although universities are more successful than PAEs.
IV.

ANALYSIS OF PAE ASSERTION PRACTICES

This Article's analysis of PAE assertion practices focuses on three
principal categories of questions and policy recommendations raised in the
"patent troll" debates, namely: (A) PAE patent quality; (B) PAE litigation
practices; and (C) PAE patent markets and opponents. The following identifies the specific questions posed, describes the analyses to evaluate them,
and reports the results.
A.

PAE Patent Quality

A major basis for concern in the "patent troll" debate is the fear that
PAEs often assert patents of poor quality and ambiguous claim scope. It is
feared that PAEs do this in order to extract settlements from a broad range
of accused infringers who, despite the weakness of the claims, prefer to pay
off the PAE than engage in costly litigation. For example, the White House
report states that PAEs extract settlement fees by "acquiring and asserting
broad patents, some of questionable validity."47 The report continues to
describe how PAEs "acquire patents whose claim boundaries are unclear,
and then (with little specific evidence of infringement) ask many companies
at once for moderate license fees, assuming that some will settle instead of
risking a costly and uncertain trial."48 To address these concerns, the report,
along with several academics, recommended enacting higher standards of
patentability, limiting software and business method patents, and enhancing
procedures to challenge patents and scrutinize patent quality. 9 This Article
47 WHIrE HOUSE REPORT, supra note 5, at 4.
48 Id.
49 Id. at 13; see also Chien, supra note 4, at4.
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studies these concerns by evaluating PAE success rates, and analyzing specific quality-related characteristics of patents they assert.
1.

PAE Success Rates

This Article conducts targeted analyses of decided PAE cases and the
patents asserted by PAEs in these cases to test the assumption that PAEs
typically assert lower-quality patents than other plaintiffs. Specifically, this
Article first studies the success rates of PAEs relative to other types of
NPEs and practicing entities, on the theory that if PAEs generally assert
lower-quality patents this should be reflected in lower success rates in cases
that are fully litigated. If PAE patents are generally of lower quality, they
are more likely to be held invalid or non-infringed in decided cases.
PAEs had approximately the same success rate as all other plaintiffs in
cases with decisions between 1995 and 2011. PAEs won 28 percent (45 out
of 160) of the cases they brought, and all other plaintiffs won 32 percent
(509 out of 1,591) of their cases. The 4 percent difference here is not statistically significant. 50 This could suggest that the cases brought by PAEs
which reach final decision are not in fact weaker on their merits than any
other case, and the patents asserted by PAEs in decided cases are not of
lower quality than other plaintiffs' patents.
2.

Quality-Related Characteristics of PAE Patents

Next, this Article studies several intrinsic quality-related characteristics of the patents asserted by PAEs in cases where they were successful, to
look for differences between PAE patents and practicing entity patents.
This Article specifically analyzes the following factors of PAE patents relative to practicing entity patents in cases finding infringement: (1) number of
claims; (2) number of forward citations; and (3) number of patents asserted.
These factors have been found to correlate with higher likelihood of a patent being asserted in the first instance," as well as higher resulting award
amounts in successful suits. 2
With respect to the number of claims, PAE patents have more claims
than those asserted in non-PAE cases with an infringement award. On average, PAE patents have 33.39 claims and the patents in other cases have
21.24 claims. This result is not strongly significant, but it could indicate

50
51
52

A chi-squared test resulted in a test statistic of 1.005 and a p-value of 0.316.
See supra note 33.
See Mazzeo, Hillel & Zyontz, supra note 26, at 69.
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patents of somewhat greater complexity being brought by PAEs.53 Furthermore, this appears to be at odds with the popular fear of PAEs asserting
very broad and vague patents of uncertain claim scope. A higher number of
patent claims suggests possibly greater specificity of claim scope, as dependent claims add limitations that further refine the metes and bounds of
the protected invention. Although there is considerable anecdotal evidence
of PAEs asserting broad and ambiguous patents, 54 case data suggest that
these individual examples might not reflect the general rule.55
With respect to the number of forward citations, there are significant
but small differences in the average number of forward citations for PAE
patents in cases finding infringement. On average, PAE patents had 22.35
forward citations and non-PAE patents had 19.27 forward citations. 5 6 Forward citations have been widely recognized to correlate with patent value
and quality, indicating a greater recognition and importance of the claimed
invention in follow-on patented technologies. The higher number of forward citations therefore also suggests, contrary to popular belief, that PAEs
on average assert higher-quality patents than non-PAEs in cases finding
infringement.
With respect to the number of patents asserted, the average number of
patents asserted by PAEs in cases awarding damages is higher than the average number of patents asserted in successful non-PAE cases.57 On average, PAEs assert 3.85 patents per case, while other plaintiffs assert 2.22
patents per case. The difference is statistically significant at the 15 percent
level at least. 8 A higher number of patents in successful cases could sug53 This analysis included 339 cases, 27 of which involve PAEs. A t-test for equal means with
unequal variances provides a t-statistic of -1.363 and a p-value of 0.184. An additional non-parametric
two-sample Wilcoxon rank-sum test was also run since the data do not follow a normal distribution
particularly well. The test statistic is z = -2.153 with a p-value of 0.031, which again suggests the differences are more significant than given by the standard t-test.
54 See, e.g., Chien, supra note 4, at 25 ("[M]any survey respondents don't find [NPE suits] to be
socially productive assertions-but rather involving frivolous or overbroad patents, and frustrating
rather than furthering competition.").
55 A similar dynamic took place around fears of the "excessiveness" of infringement awards.
Although there were a few very large awards that garnered substantial media attention and aggravated
popular concem, these were substantially larger than the vast majority of awards and resulted in a highly
skewed distribution. Mazzeo, Hillel & Zyontz, supra note 26, at 63.
56 This analysis included 339 cases, 27 of which involve PAEs. A t-test for equal means with
unequal variances provides a t-statistic of -0.725 and a p-value of 0.473. An additional non-parametric
two-sample Wilcoxon rank-sum test was also run since the data do not follow a normal distribution
particularly well. The test statistic is z = - 1.683 with a p-value of 0.092.
57 These analyses use awards granted from 1995 to 2008 in the dataset.
58 Total cases for this analysis equal 339, 27 of which are PAE cases. A t-test for equal means
with unequal variances provides a t-statistic of -1.505 and a p-value of 0.144. An additional nonparametric two-sample Wilcoxon rank-sum test was also run since the data do not follow a normal
distribution particularly well. The test statistic is z = -2.313 with a p-value of 0.021, which suggests the
differences are more significant than given by the standard t-test.
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gest more robust and meritorious claims of infringement, although it also
suggests greater complexity in these cases, which could increase litigation
costs on both sides.
Taken together, to the extent these characteristics are robust indicators
of patent quality, PAEs appear to assert patents of at least equal, if not
greater, quality as compared to those asserted by other plaintiffs in cases
awarding damages for infringement.
B.

PAE Litigation Practices

Certain patent assertion practices often associated with PAEs have
been cited as abusive and opportunistic in the "patent troll" debate. This
Article investigates the prevalence of these practices and compares them to
litigation activity by other patent plaintiffs. Specifically, this Article studies: (1)PAE decision rates; (2) the length of PAE litigations; and (3) typical
venues of PAE cases.
1.

PAE Decision Rates

It has widely been complained that "PAEs often threaten to sue with
the intention of extracting license fees or settlement payments."59 Indeed,
this approach to patent assertion is consistent with the incentives involved
in litigation by PAEs-injunctions are generally not available to PAEs under eBay Inc. v. MercExchange, L.L.C.,6' and given that they do not compete in the relevant markets PAEs cannot prove lost profits and therefore
are predominantly entitled to reasonable royalties as their measure of damages.6 PAEs also do not derive indirect benefits from tying up defendants
in costly litigation-unlike practicing entities, they do not stand to gain
market share or tarnish their opponents' reputations. Accordingly, it may
often be preferable for a PAE to settle its lawsuit for some amount equal to
or greater than the expected reasonable royalty award, less litigation fees
and expenses avoided (and discounted for time value and uncertainty).
PAE decision rates are consistent with this incentive structure. For instance, a recent GAO report found that PAEs filed 59 percent of all patent
lawsuits filed in the United States in 2012, and data from previous years
show increasing proportions toward this high mark.62 However, the propor59

WHITE HOUSE REPORT, supra note 5, at 6.

60 547 U.S. 388 (2006). It would also be useful to investigate whether PAE incentives to settle
have changed after the eBay decision.
61 See Panduit Corp. v. Stahlin Bros. Fibre Works, Inc., 575 F.2d 1152, 1157 (6th Cir. 1978).
62 Sara Jeruss et al., The America Invents Act 500: Effects of Patent Monetization Entities on US
Litigation, 11 DUKE L. & TECH. REV. 357, 357 (2012).
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tion of NPEs in decided cases-wins and losses combined-has remained
relatively constant through 2011 (although the proportion of PAE cases has
increased to some extent). On average, PAE cases account for only 9 percent of all cases in which there was a final decision on the merits.63 This
difference between filings and decisions provides some support for the hypothesis that PAEs often have greater incentives to settle their suits than
practicing entities.'
2.

Length of PAE Litigations

It has recently been posited that PAEs are more likely to prolong their
lawsuits with the intent of driving up their opponents' litigation expenses
and potential settlement value. The White House report states that "PAEs
have an incentive to drag out litigation, to increase pressure on defendants
to settle the case."65 The report cites studies suggesting that the risks and
costs of litigation favor PAEs, "whose legal fees are low (since they do not
have to provide much evidence to assert that there has been patent infringement), and who do not have to pay the fixed costs of a manufacturing
operation."' Others, such as Professor Chien, have raised concerns over the
impact on the defendant's operations during the pendency of a PAE trial,
arguing that these burdens are particularly harmful to start-ups and other
small entities.67
There is some theoretical basis to question the claim that PAEs benefit
from longer rather than shorter litigation. Given that PAEs are generally not
entitled to injunctions or lost profits, defendants in PAE cases might actually face lower operational risks than defendants sued by patent holders who
practice their patents or compete in the same markets. Defendants sued by
PAEs face a lower risk of preliminary injunctions, which immediately interrupt the accused activity and could impose massive operational costs. These
defendants also typically do not face the risk of permanent injunctions at
the conclusion of the lawsuit, which could be disruptive to the extent they
remain engaged in the infringing activity. Also, without lost profits available, the measure of damages shifts to a royalty on the defendant's revenues
derived from the infringing product, which the defendant may have more
ability to control and which accordingly may pose less risk than lost profit
63

See id. at 386.

64 See supra Part Ill. As noted above, though, other factors in addition to settlements likely contribute to the disparity between case filings and decision rates, such as dismissals, consolidations, and
other case dispositions. Also, the incentives of both parties are relevant in actual settlement agreements.
65 WHITE HOUSE REPORT, supra note 5, at 6 (citing Catherine Tucker, Patent Trolls and Technology Diffusion 4-5 (Mar. 26, 2013) (unpublished manuscript), available at http://papers.ssrn.com/sol3/
papers.cfm?abstractid=21369554).
66

Id.

67

Chien, supra note 4, at 16-17.
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damages. This suggests that PAEs might in fact derive fewer benefits from
protracted litigation than practicing entities.
Information about the length of decided litigations provides direct data
to investigate this point. This Article measures the number of days between
the initial complaint and start of trial for PAE and non-PAE cases that went
to trial and resulted in an award.68 From 1995 through 2008, there was no
statistical difference between the length of PAE and non-PAE cases. On
average, PAE cases lasted 935 days (2.56 years) from complaint to trial and
non-PAE case lasted 1,026 days (2.81 years).6 9 This Article also conducted
the same analysis on cases awarding damages for infringement which were
decided from 1995 through 2011. Once again, there was no significant difference in the length of litigation for PAE cases relative to non-PAE cases.
Over the longer 1995 to 2011 time frame, PAE cases lasted 1,014 days
(2.78 years) on average and non-PAE cases lasted 1,040 days (2.85 years)
on average.7 °
3.

PAE Venue

Venue in patent cases is a highly contentious issue, and PAEs in particular have long been accused of forum shopping by bringing suit in courts
favorable to them and inconvenient to their defendants. Certain U.S. district
courts-the Eastern District of Texas being the most notable example-are
known to be hotbeds of PAE activity. Part of the issue is based in the federal laws governing venue, under which a defendant may be sued in any U.S.
district court that has personal jurisdiction over the defendant for that suit.
Personal jurisdiction in patent cases is often satisfied if the defendant has
sold or offered for sale the accused product in the relevant district. 7' Accordingly, many defendants find themselves sued in districts far from their
principal places of business, which raises the costs and inconvenience of
72
litigation if they cannot achieve transfer to a more favorable venue.

68 Based on cases decided through 2008 in which the patent holder was successful.
69 This analysis included 281 cases, 25 of which involve PAEs. A t-test for equal means with
equal variances provides a t-statistic of 0.696 and a p-value of 0.492. An additional non-parametric twosample Wilcoxon rank-sum test was also run. The test statistic is z = 0.191 with a p-value of 0.849.
70 This analysis included 416 cases, 35 of which involve PAEs. A t-test for equal means with
equal variances provides a t-statistic of 0.288 and a p-value of 0.775. An additional non-parametric twosample Wilcoxon rank-sum test was also run. The test statistic is z = -0.446 with a p-value of 0.656.
71 28 U.S.C. § 1400(b) (2006); see VE Holding Corp. v. Johnson Gas Appliance Co., 917 F.2d
1574, 1577-78 (Fed. Cir. 1990).
72

Jake Holdreith, IP: The Failure of Venue and Joinder Reform in Patent Litigation, INSIDE

COUNSEL (Apr. 9, 2013), http://www.insidecounsel.com2013/04/09/ip-the-failure-of-venue-and-joinder
-reform-in-pate (discussing venue transfer on motion and other litigation practices after passage of the
AlA).
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Empirically, there is also evidence that certain venues are particularly
favorable to PAEs. For example, the 2013 PwC Study found that 39 percent
of all NPE decided cases from 1995 to 2012 were concentrated in five district courts, with the Eastern District of Texas having the highest percentage
of decisions. 3 The Eastern District of Texas also has one of the highest

overall success rates for NPE plaintiffs relative to other districts.74
This Article finds very similar results in the data on PAEs from 1995
to 2011. Approximately 50 percent of PAE cases are concentrated in five
district courts: the Eastern District of Texas, the Northern District of Illinois, the District of Delaware, the Northern District of California, and the
Central District of California. The Eastern District of Texas also provided
PAEs the highest win rate of any district court that saw at least five PAE
cases. None of these results were driven by a single PAE litigating many
times in any one place.
These results are also in line with those of non-PAE cases. The same
courts appear at the top of both lists, and both types of plaintiffs have similar success rates. The only difference is that the Central District of California appears a bit further down the list for non-PAEs. To that end, it is not
clear that PAEs engage in forum shopping to a greater extent than any other
patent plaintiffs.
C.

PAE PatentAcquisitions and Opponents
1.

Age and Assignment History of PAE Patents When Asserted

Another core concern about PAE litigation is that it extracts aftermarket value from patents at the expense of practicing entities as PAEs
assert claims from older patents after the inventions have disseminated
through the relevant industries. For example, PAEs have been noted to acquire portfolios from defunct entities whose technologies have entered the
marketplace. Whereas practicing entities might face barriers to asserting
these patents-for example, the threat of "blocking patents" being asserted
against them in retaliation and the necessity of a cross-license to continue
practicing their rights-PAEs may have more freedom to bring such claims
because they do not manufacture or sell products that could be the basis of
infringement claims. Furthermore, older patents may increase the risk of
holdup, whereby irreversible investments may have been made in the technology, preventing design-around and other efforts to avoid ongoing infringement.

73 2013 PWC STUDY, supra note 28, at 24.
74

id.
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With respect to patent age, there is no difference in patent age at the
time of trial for PAE and non-PAE plaintiffs that win in court. The average
patent age at trial is 2,149 days (5.89 years) for PAEs and 2,318 days (6.35
years) for non-PAEs.75 This difference is not statistically significant, so it
does not appear that PAEs generally asserted older patents in cases awarding damages for infringement.
Similarly, this Article examined the number of assignments prior to litigation of PAE patents versus practicing entity patents. If PAEs acquire
their patents predominantly through after-market transactions, one would
expect to see more assignments on average in patents asserted by PAEs
than by practicing entities. In cases decided from 1995 to 2008, there is a
significant (at the 5 percent level) but very small difference in the average
number of assignees to the patents on which damages were awarded for
PAEs relative to non-PAEs, with PAE patents having a slightly higher
number of prior assignments.7 6 PAE patents had 1.481 assignees on average
whereas non-PAE patents had 1.317 assignees on average.77
According to both of these parameters, patent age and number of assignments, patents asserted by PAEs look very similar to patents asserted
by practicing entities in cases awarding damages for infringement.
2.

Size of Defendants in PAE Suits

Professor Chien and others have focused on particular issues that arise
when start-ups are sued by PAEs.75 Although any litigation exposure is
harmful for a fledgling business, patent infringement suits are often considered to be especially difficult to predict and avoid in certain technology
fields, particularly in the Silicon Valley information and computer technology industries, where software patents, component-based inventions, and
mobile technology are prevalent. 79 Professor Chien's survey data also suggest that PAEs often target start-up companies who are on the verge of venture capital financing rounds, acquisitions, and other major transactions, in
order to drive up settlement values."

75 This analysis used awards granted from 1995 to 2008 in the dataset. It included 338 cases, 27 of
which involve PAEs. A t-test for equal means with equal variances provides a t-statistic of 0.473 and a
p-value of 0.637. An additional non-parametric two-sample Wilcoxon rank-sum test was also run. The
test statistic is z = 0.431 with a p-value of 0.666.
76 Further work is required to determine the exact assignment histories of these patents.
77 This analysis included 339 cases, 27 of which involve PAEs. A t-test for equal means with
equal variances provides a t-statistic of -1.296 and a p-value of 0.196. An additional non-parametric
two-sample Wilcoxon rank-sum test was also run. The test statistic is z = -2.07 with a p-value of 0.038.
78 See Chien, supra note 4, at 16-17.
79
80

See id. at 3-5.
Id. at 1-12.
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This Article examines the entity size of all patent defendants sued by
both PAEs and non-PAEs across the dataset, to determine whether, among
decided cases, a significant difference can be observed in the entity size of
the defendant. PAEs tend to sue Fortune 500 firms more often than nonPAEs, although the difference is not significant.81 PAEs sued Fortune 500
defendants in 22 percent of their cases and non-PAEs sued Fortune 500
defendants in 13 percent of their cases in which damages were awarded.82
This data could suggest that patent assertions by practicing entities, as compared to suits by PAEs, pose an equal or greater threat to start-ups. 3 How-

ever, as mentioned above, given that the data include only decided cases,
this result may be driven in part by smaller entities settling before a final
judgment-data on cases filed by PAEs versus practicing entities and the
size of the defendants sued by them respectively would need to be studied
directly to confirm.
V.

CONCLUSIONS

The findings in this Article reveal a number of important facts about
PAEs and their patent assertion practices, some of which are directly contrary to popular positions in the "patent troll" debate. Rather, in some respects the data paint a very different picture of PAEs, showing them in
some cases to assert patents and conduct litigation in ways that are highly
similar to other patent holders enforcing their rights. From the perspective
of decided cases, it is very difficult to distinguish the "trolls" from any other patent plaintiff.
Some important caveats should be noted. This- Article does not address
settled cases directly, or demand letters and licensing arrangements that do
not involve litigation,"4 and it is possible that PAEs significantly differ from
practicing entities when it comes to out-of-court assertion practices. However, as discussed above, decided cases provide useful information on assertion generally and the expectations of parties in settlement and licensing
negotiations. At a minimum, these findings highlight the need to empirically study patent assertion practices in their various forms before robust conclusions can be drawn and policies can be implemented. Also, the dataset
focuses primarily on cases finding infringement (with the exception of suc81 This analysis uses awards granted from 1995 to 2008 in the dataset.
82 In this analysis there were 340 cases, 27 of which were PAEs. A chi-squared test resulted in a
test statistic of 1.589 and a p-value of 0.207 (Fisher's exact = 0.244).
83 Notably, the data afford only a partial picture as they do not include settlements, and start-ups
might in fact settle significantly more frequently when sued by PAEs than by practicing firms. The
absolute incidence of suits by PAEs against start-ups and magnitude of resulting liabilities and other
costs are necessary to complete the picture.
84 See GAO PATENT ASSERTION STUDY, supra note 3, at 26 ("[Piatent assertion occurs without
firms ever filing lawsuits....").
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cess rates and certain other findings that include patent-holder losses), and
the number of PAE cases in the dataset is relatively low, so some refinement to these results can be expected with more data.
To briefly summarize the results of this Article, regarding patent quality, there is no evidence of PAEs generally asserting lower-quality patents or
litigating cases that are weaker on their merits than other patent holders.
Instead, in some instances there is evidence of PAEs asserting higherquality patents than other plaintiffs in cases where damages were awarded.
This could indicate that PAEs are developing specialized expertise at patent
assertion and are being highly selective about the patents they acquire and
assert.
Regarding litigation practices, there is no evidence of PAEs "drawing
out" their lawsuits to a greater extent than other patent holders. Also, there
are no significant differences in venue for PAE cases compared with other
patent holders. Accordingly, to the extent the district concentrations observed indicate forum shopping by PAEs, non-PAE plaintiffs appear to
engage in similar tactics. These results suggest further similarity between
PAEs and practicing entities in the ways they litigate their patent suits.
Regarding patent acquisitions by PAEs and the types of companies
they target in assertion, contrary to popular belief, PAEs do not appear to
assert significantly older patents than other patent holders. PAE defendants
appear to be roughly the same size as or possibly larger than defendants
sued by practicing entities across decided cases awarding damages. Additional work is needed to determine which types and sizes of entities PAEs
are likely to sue, and the magnitude of the impact that PAEs have on startups and other small entities.
On the whole, the findings of this Article suggest that the realities of
PAE assertion practices are complex, and it is difficult to identify clear
signs of abuse or misuse of their patents relative to other patent plaintiffs.
Rather, the observable similarities between PAEs and practicing entities
highlight the risk that attempts to limit PAEs' enforcement rights or restrict
the remedies available to them could inadvertently affect all patent holders
and cause adverse effects on the ability of practicing entities to enforce and
otherwise monetize their patents. These results counsel caution in designing
policies aimed at PAEs and patent assertion practices.
Moreover, these results further indicate that modern patent assertion
practices may yield unique efficiencies and benefits relative to traditional
enforcement actions by practicing firms. It is necessary to understand the
relationship between modem patent assertion, patent monetization, and
patent value in its variety of forms before it may be identified which practices "promote progress" and which prevent it. True "patent trolls" are difficult to find, and all patent rights are at issue in the hunt to apprehend
them.

